Abstract:Background To explore the clinical phenotype and long-term outcome in children with genetic causes of early-onset epileptic encephalopathies. Methods The clinical data of 118 children between 2010 and 2020 was obtained and analyzed. The whole exome sequencing and copy number variation studies in family were used to find pathogenic mutations. The confirmed mutations were verified by Sanger sequencing. Results Among 118 patients, 39 patients were diagnosed with DS, 18 were WS, 3 were OS, 3 were EME, 2 were MMFSI, 1 was GLUT1 deficiency syndrome, 1 was Pyridoxine dependent epilepsy and 51 were non-symptomatic EOEEs. The initial EEG showed frequent multiple and multifocal sharp waves, spike waves, sharp slow waves or spike slow waves. In the later period, some transformed into infrequent discharging or normal EEG. 112 patients (112/118, 94.9%) showed normal brain MRI, and the remaining 6 had widened extracerebral space. In the later stage, 115 patients were re-examined with brain MRI 1 to 3 times, the widened gap became normal, only 2 had mild brain atrophy. After treatment, 42 patients (42/118, 35.6%) had seizure control. In EOEE-BS, 6 patients were found KCNQ2 mutations and the remaining mutations were SCN2A (n=2), STXBP1 (n=1). After treatment, only 2 patients had seizure control, 6 had uncontrolled seizures and 1 died. 7 patients with dyskinesia were found. 1 patient starting with a febrile convulsion was caused by HNRNPU mutation. SCN1A mutations were detected in 38 patients (38/118, 32.2%), representing the largest proportion. The second common mutations were KCNQ2 mutations in 9 patients. The third one was CDKL5 mutations in 8 patients. Genes associated with ionic channels represented the largest proportion (66/118, 55.9%), sodium channel potassium channel and calcium channel respectively. In WS, we detected SCN3A, SCN2A, SCN8A, CACNA1H, DEPDC5, MECP2, DYNC1H1, CDKL5, ALG11, CCDC88C, GABAA1, IL1RAPL1, RNASEH2B, SLC19A3, STXBP1, QARS, COL4A2 mutations . In addition to common gene mutations, we reported rare possible pathogenic genes: CCDC88C , IL1RAPL1, RNASEH2B and COL4A2 in WS. In non-syndromic genetic causes of EOEEs, we detected rare possible pathogenic genes: SETBP1, DPYD, CSNK2B and H3F3A. As for genetic modes, denovo heterozygous mutations account for the largest proportion (104/118, 88.1%). 3 patients with SMC1A mutations response to KD add-on therapy. VPA added treatment showed good effects on KCNB1 and PACS2 encephalopathy. LEV showed good effects on STXBP1 , and OXC showed good effects on SCN8A encephalopathy. Conclusion The clinical manifestations of EOEE are variable, including dyskinesia. EOEE-BS usually response poorly to AEDS therapy. Although some patients achieve seizure-free, there is no remarkable improvement in their development. EOEEs starting with a febrile convulsion may be a special phenotype of HNRNPU related neurodevelopmental syndrome, similar to DS. We report rare possible pathogenic genes: CCDC88C , IL1RAPL1, RNASEH2B , COL4A2 in WS and detect rare possible pathogenic genes: SETBP1, DPYD, CSNK2B and H3F3A in non-syndromic genetic causes of EOEEs . Although genetic causes of EOEEs response poorly to AEDS treatment, we find that some gene mutation related EOEEs receive good effects on specific AEDS.

Early life seizures and epileptic spasms in STXBP1‐related disorders

Delineating clinical and developmental outcomes in STXBP1-related disorders

Assessing the Landscape of STXBP1-related Disorders in 534 Individuals

Epilepsy Course and Developmental Trajectories in STXBP1-DEE

Genotype and phenotype spectrum of 10 children with STXBP1 gene-related encephalopathy and epilepsy

Early mortality in STXBP1-related disorders

A De Novo Splicing Mutation of STXBP1 in Epileptic Encephalopathy Associated with Hypomyelinating Leukodystrophy

Efficacy of levetiracetam in STXBP1 encephalopathy with different phenotypic and genetic spectra

Clinical spectrum of STX1B-related epileptic disorders

Confirming the Contribution and Genetic Spectrum of De Novo Mutation in Infantile Spasms: Evidence from a Chinese Cohort

GABAergic/glycinergic and glutamatergic neurons mediate distinct neurodevelopmental phenotypes of STXBP1 encephalopathy

Clinical and electroencephalography characteristics of 41 children with epileptic spasms onset after 1 year of age

Deciphering the dynamic clinical patterns in -related disorders using real-world data

Epilepsies with onset during the first year of life: A prospective study on syndromes, etiologies, and outcomes

Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapies

Phenotypic Spectrum and Long-term Outcome in Children with Genetic Causes of Early-onset Epileptic Encephalopathy

ENVISIONing a critical period to preserve development: communication delays in SCN1A+ dravet syndrome

Timing the clinical onset of epileptic spasms in infantile epileptic spasms syndrome: A tertiary health center's experience

Intellectual development before and after the onset of infantile spasms: A controlled prospective longitudinal study in tuberous sclerosis

Mutation in the STXBP1 Gene Associated with Early Onset West Syndrome: A Case Report and Literature Review

Response to treatment in a prospective national infantile spasms cohort